NIH plans to fund early-career researchers (R01, no clinical trials) for projects representing a significant change in their research direction, aligning with NIH's scientific interests.
Funder: National Institutes of Health
Due Dates: January 26, 2027 (New) | February 26, 2027 (Resubmission) | May 28, 2027 (New) | June 28, 2027 (Resubmission) | September 28, 2027 (New) | October 28, 2027 (Resubmission) | January 26, 2028 (New) | February 24, 2028 (Resubmission) | May 26, 2028 (New) | June 27, 2028 (Resubmission) | August 25, 2028 (Closing) | August 26, 2028 (Expiration)
Funding Amounts: Budgets are not limited but must reflect project needs; project periods up to 5 years
Summary: Supports innovative research representing a new direction for NIH-designated early stage investigators, without preliminary data.
Key Information: Applications containing preliminary data will be withdrawn; clinical trials are not allowed.
The NIH Stephen I. Katz program provides an R01 pathway for early stage investigators (ESIs) pursuing innovative research in a new direction for which preliminary data do not exist. Projects must fit the scientific mission and programmatic interests of at least one participating NIH Institute or Center. The program encourages new approaches to solving problems across a broad range of health-related research.
The proposed work may build on an investigator’s expertise, but cannot be an incremental advancement, expansion, or extension of previous research. A change could involve a new methodology, discipline, therapeutic target, or paradigm. Feasibility must be justified through the conceptual framework, published evidence, and compelling logic rather than preliminary data. Investigators proposing work consistent with past research or supported by preliminary data are directed to other funding opportunities.